457 related articles for article (PubMed ID: 11149950)
1. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
Laffitte BA; Repa JJ; Joseph SB; Wilpitz DC; Kast HR; Mangelsdorf DJ; Tontonoz P
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):507-12. PubMed ID: 11149950
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
Ulven SM; Dalen KT; Gustafsson JA; Nebb HI
J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368
[TBL] [Abstract][Full Text] [Related]
3. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
4. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.
Liang Y; Lin S; Beyer TP; Zhang Y; Wu X; Bales KR; DeMattos RB; May PC; Li SD; Jiang XC; Eacho PI; Cao G; Paul SM
J Neurochem; 2004 Feb; 88(3):623-34. PubMed ID: 14720212
[TBL] [Abstract][Full Text] [Related]
5. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.
Li Y; Bolten C; Bhat BG; Woodring-Dietz J; Li S; Prayaga SK; Xia C; Lala DS
Mol Endocrinol; 2002 Mar; 16(3):506-14. PubMed ID: 11875109
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
7. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
Murthy S; Born E; Mathur SN; Field FJ
J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
[TBL] [Abstract][Full Text] [Related]
8. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
[TBL] [Abstract][Full Text] [Related]
11. Role of p160 coactivator complex in the activation of liver X receptor.
Huuskonen J; Fielding PE; Fielding CJ
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):703-8. PubMed ID: 14764426
[TBL] [Abstract][Full Text] [Related]
12. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
13. Autoregulation of the human liver X receptor alpha promoter.
Laffitte BA; Joseph SB; Walczak R; Pei L; Wilpitz DC; Collins JL; Tontonoz P
Mol Cell Biol; 2001 Nov; 21(22):7558-68. PubMed ID: 11604492
[TBL] [Abstract][Full Text] [Related]
14. Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E.
Lee J; Tauscher A; Seo DW; Oram JF; Kuver R
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G630-41. PubMed ID: 12773300
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.
Repa JJ; Berge KE; Pomajzl C; Richardson JA; Hobbs H; Mangelsdorf DJ
J Biol Chem; 2002 May; 277(21):18793-800. PubMed ID: 11901146
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ASC-2 as an antiatherogenic transcriptional coactivator of liver X receptors in macrophages.
Kim GH; Park K; Yeom SY; Lee KJ; Kim G; Ko J; Rhee DK; Kim YH; Lee HK; Kim HW; Oh GT; Lee KU; Lee JW; Kim SW
Mol Endocrinol; 2009 Jul; 23(7):966-74. PubMed ID: 19342446
[TBL] [Abstract][Full Text] [Related]
17. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver.
Sabol SL; Brewer HB; Santamarina-Fojo S
J Lipid Res; 2005 Oct; 46(10):2151-67. PubMed ID: 16024918
[TBL] [Abstract][Full Text] [Related]
18. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice.
Terasaka N; Hiroshima A; Koieyama T; Ubukata N; Morikawa Y; Nakai D; Inaba T
FEBS Lett; 2003 Feb; 536(1-3):6-11. PubMed ID: 12586329
[TBL] [Abstract][Full Text] [Related]
19. The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines.
Nishimaki-Mogami T; Tamehiro N; Sato Y; Okuhira K; Sai K; Kagechika H; Shudo K; Abe-Dohmae S; Yokoyama S; Ohno Y; Inoue K; Sawada J
Biochem Pharmacol; 2008 Oct; 76(8):1006-13. PubMed ID: 18761326
[TBL] [Abstract][Full Text] [Related]
20. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
